Living guidance for clinical management of COVID-19
Overview
The WHO COVID-19 Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal
care of COVID-19 patients throughout their entire illness is important.
The (second) latest version of this living guidance is available in both pdf format (via the ‘Download’ button) and via an online platform,
and is updated regularly as new evidence emerges.
The (third) latest version of this living guidance is available in both pdf format (via the ‘Download’ button) and via an online platform, and is updated regularly as new evidence emerges.
This updated (third) version contains two new recommendations regarding hospitalized children with Multisystem Inflammatory Syndrome (MIS-C), which includes a:
- conditional recommendation to use corticosteroids in addition to supportive care (rather than either IVIG plus supportive care, or supportive care alone), for hospitalized children aged 0-18 years who meet a standard case definition for MIS-C;
- conditional recommendation to use corticosteroids in addition to standard of care for hospitalized children aged 0-18 years who meet both a standard case definition for MIS-C and diagnostic criteria for Kawasaki disease.
Guidelines regarding the use of drugs to treat COVID-19 are included in a separate WHO document, Therapeutics and COVID-19: living guideline, that can via an online platform and in
pdf format
(or click ‘PDF’ in top right corner of online platform).
Guidelines regarding the use of drugs to prevent COVID-19 are included in a separate document, WHO Living guideline: Drugs to prevent COVID-19, that can be accessed via an online platform and in pdf format (or click ‘PDF’ in top right corner of online platform).
To view previous (now outdated) versions of this guideline, please see the links below:
- First version, published 27 May 2020 (accessible as pdf only), was originally published under the title "Clinical management of COVID-19: interim guidance, 27 May 2020".
- Second version, published 25 January 2021 (access via an online platform or as pdf).
